Clinical Trial Update: Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response [Phase 4]

View source ↗

Summary

Phase 4 study comparing monodose and multidose presentations of GlaxoSmithKline's Hepatitis B vaccine in terms of immune response. The trial status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED